Literature DB >> 1386336

Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins.

Y Xiong1, J Menninger, D Beach, D C Ward.   

Abstract

A human D-type cyclin gene (CCND1/cyclin D1/PRAD1) was previously isolated by virtue of its ability to complement a triple G1 cyclin (Cln) deficiency of Saccharomyces cerevisiae and was also identified as a candidate BCL1 oncogene. We now report the molecular cloning of two additional human D-type cyclin genes, CCND2 (cyclin D2) and CCND3 (cyclin D3). All three human D-type cyclin genes encode small (33-34 kDa) proteins that share an average of 57% identity over the entire coding region and 78% in the cyclin box. The D-type cyclins are most closely related to cyclin A (39% identity) and cyclin E (36%), followed by cyclin B (29%) and cyclin C (21%). Isolation and characterization of genomic clones revealed two pseudogenes corresponding to CCND2 and CCND3, respectively. All three cyclin D genes are interrupted by an intron at the same position. CCND2 has been mapped to chromosome 12p13, and CCND3 has been mapped to chromosome 6p21.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386336     DOI: 10.1016/0888-7543(92)90127-e

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  38 in total

1.  High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.

Authors:  C A Werner; H Döhner; S Joos; L H Trümper; M Baudis; T F Barth; G Ott; P Möller; P Lichter; M Bentz
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 3.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

4.  A family of cyclin D homologs from plants differentially controlled by growth regulators and containing the conserved retinoblastoma protein interaction motif.

Authors:  R Soni; J P Carmichael; Z H Shah; J A Murray
Journal:  Plant Cell       Date:  1995-01       Impact factor: 11.277

Review 5.  Progress against cancer.

Authors:  S Broder; J E Karp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Clinical correlation of cyclin D2 mRNA expression in human luteinized granulosa cells.

Authors:  D Choi; E Y Lee; S Yoon; S Hwang; B K Yoon; J H Lee
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

7.  Expression of cyclins E1 and E2 during mouse development and in neoplasia.

Authors:  Y Geng; Q Yu; W Whoriskey; F Dick; K Y Tsai; H L Ford; D K Biswas; A B Pardee; B Amati; T Jacks; A Richardson; N Dyson; P Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

8.  Genetic replacement of cyclin D1 function in mouse development by cyclin D2.

Authors:  Bradley C Carthon; Carola A Neumann; Manjusri Das; Basil Pawlyk; Tiansen Li; Yan Geng; Piotr Sicinski
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

9.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Authors:  E A Musgrove; J A Hamilton; C S Lee; K J Sweeney; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  cDNA cloning, sequence identification and tissue expression distribution of three novel porcine genes: UCHL3, RIT1 and CCND3.

Authors:  G Y Liu
Journal:  Mol Biol Rep       Date:  2008-01-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.